Twelve People Bought Cocaine in Luzerne County This Summer. It Was Fentanyl.

If you use cocaine and think fentanyl is someone else’s problem, Luzerne County, Pennsylvania just spent three months proving that’s no longer true.

On September 8, county officials issued a public warning after 12 people died in three months from cocaine contaminated with fentanyl, sourced through a supply chain that runs from China through Mexico. “When it’s mixed with fentanyl, it becomes immediately a potential death situation,” District Attorney Sam Sanguedolce told reporters — a plain sentence carrying an ugly fact: most of the 12 didn’t know they’d taken an opioid at all. The victims ranged from 19 to 71 years old.

Zoom out and the county’s overall numbers look like good news: 35 overdose deaths so far this year, against 71 for all of 2025. That’s the story you’d want to lead with, if the fentanyl-cocaine cluster weren’t sitting right underneath it, pulling in the opposite direction. County Coroner Dion Fernandes, County Manager Romilda Crocamo, Human Services division head Megan Stone, and drug-and-alcohol administrator Michael Gagliardi all signed onto the same warning — the kind of unified front local officials reach for when they’re worried a real decline is about to get erased by one contaminated batch.

Here’s the part that should change how you think about this, not just react to it: cocaine and methamphetamine have no FDA-approved medication treatment. None — not a buprenorphine equivalent, not a naltrexone analog, nothing that functions the way methadone or Suboxone functions for opioids. Stimulants were involved in an estimated 35,000 overdose deaths nationally in 2023 for methamphetamine alone, another 30,000 for cocaine, and the reason those numbers stay this high isn’t a mystery — it’s that the entire pharmaceutical toolkit built to blunt opioid deaths over the last decade simply doesn’t apply here. When a stimulant is cut with fentanyl, the treatment system built to respond has almost nothing to reach for except the same opioid tools, applied to someone who never meant to touch an opioid.

The thing that works — contingency management, where negative drug screens earn small, real incentives — is behavioral, not chemical, which is exactly why it’s been chronically underfunded next to a system built around prescriptions. It doesn’t stop a bag from being cut with fentanyl. It’s not a fast fix for a county in the middle of an active cluster.

What is fast: fentanyl test strips work on cocaine and meth, not just heroin — dip before you use, every time, no exceptions, even with a dealer you trust, because your dealer may not know either. And naloxone reverses a fentanyl overdose regardless of what drug carried it in. Neither of those requires waiting on Washington. Both are still yours to reach for tonight.